Tags

Type your tag names separated by a space and hit enter

Isoniazid-resistant tuberculosis: A problem we can no longer ignore.
PLoS Med 2020; 17(1):e1003023PM

Abstract

Giorgia Sulis and Madhukar Pai discuss the global distribution, and approaches to diagnosis and treatment, of isoniazid-resistant tuberculosis.

Authors+Show Affiliations

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. McGill International TB Centre, McGill University, Montreal, Quebec, Canada.Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada. McGill International TB Centre, McGill University, Montreal, Quebec, Canada. Manipal McGill Program for Infectious Diseases, Manipal Centre for Infectious Diseases, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31961857

Citation

Sulis, Giorgia, and Madhukar Pai. "Isoniazid-resistant Tuberculosis: a Problem We Can No Longer Ignore." PLoS Medicine, vol. 17, no. 1, 2020, pp. e1003023.
Sulis G, Pai M. Isoniazid-resistant tuberculosis: A problem we can no longer ignore. PLoS Med. 2020;17(1):e1003023.
Sulis, G., & Pai, M. (2020). Isoniazid-resistant tuberculosis: A problem we can no longer ignore. PLoS Medicine, 17(1), pp. e1003023. doi:10.1371/journal.pmed.1003023.
Sulis G, Pai M. Isoniazid-resistant Tuberculosis: a Problem We Can No Longer Ignore. PLoS Med. 2020;17(1):e1003023. PubMed PMID: 31961857.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Isoniazid-resistant tuberculosis: A problem we can no longer ignore. AU - Sulis,Giorgia, AU - Pai,Madhukar, Y1 - 2020/01/21/ PY - 2020/1/22/entrez PY - 2020/1/22/pubmed PY - 2020/1/22/medline SP - e1003023 EP - e1003023 JF - PLoS medicine JO - PLoS Med. VL - 17 IS - 1 N2 - Giorgia Sulis and Madhukar Pai discuss the global distribution, and approaches to diagnosis and treatment, of isoniazid-resistant tuberculosis. SN - 1549-1676 UR - https://www.unboundmedicine.com/medline/citation/31961857/Isoniazid-resistant_tuberculosis:_A_problem_we_can_no_longer_ignore L2 - http://dx.plos.org/10.1371/journal.pmed.1003023 DB - PRIME DP - Unbound Medicine ER -
Unbound Prime app for iOS iPhone iPadUnbound PubMed app for AndroidAlso Available:
Unbound MEDLINE
Unbound PubMed app for Windows